Veracyte to Unveil Practice-Changing Genomic Diagnostics Data Across Multiple Oncology Indications at 2021 ASCO - Seite 2

First Author:

Peter Mazzone, M.D., M.P.H., Cleveland Clinic

 

 

Title:

A prospective Validation of the genomic classifier defines high-metastasis risk in a subset of African American men with early localized prostate cancer: VanDAAM study. (oral presentation)

Abstract #:

5005

First Author:

Kosj Yamoah, M.D., Ph.D., Moffitt Cancer Center

Time:

June 8, 2021, 8:00-11:00 a.m. EDT

 

 

Title:

The impact of Percepta Genomic Sequencing Classifier (GSC) on clinical decision making in patients with a high- risk lung nodule. (poster presentation)

Abstract #:

8549

First Author:

Sonali Sethi, M.D., Cleveland Clinic

 

 

Title:

Validation of the Decipher Genomic Classifier (GC) in SAKK 09/10: A Phase III Randomized Trial of Dose-Escalated Salvage Radiotherapy (SRT) after Radical Prostatectomy (RP). (poster presentation)

Abstract #:

5010

First Author:

Alan Dal Pra, M.D., University of Miami Health System

 

 

Title:

NTRK, RET, BRAF, and ALK Fusions in Thyroid Fine-Needle Aspirates (FNAs). (poster presentation)

Abstract #:

6083

First Author:

Lori J. Wirth, M.D., Massachusetts General Hospital